Ultrasound developer Biosound Esaote reported last month that it has brokered a partnership with Summit Medical Technologies of Arlington Heights, IL. The deal gives Summit exclusive U.S. marketing rights to Indianapolis-based Biosound's Advanced
Ultrasound developer Biosound Esaote reported last month that it has brokered a partnership with Summit Medical Technologies of Arlington Heights, IL. The deal gives Summit exclusive U.S. marketing rights to Indianapolis-based Biosound's Advanced Ultrasonography (AU) line of scanners. Summit will sell the units to radiologists, medical imaging centers, and breast imaging centers, while Biosound's sales force will continue to sell the system to remaining markets, including cardiology, vascular and general surgery, and neurology.
The most recent system in the AU family is AU5, introduced last year and cleared by the Food and Drug Administration this September (SCAN 9/17/97). Biosound hopes the deal with Summit Medical will give it increased access to the multispecialty radiology market and the women's health market.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.